HR Execs on the Move

Avrick Direct

www.avrick.com

 
Avrick Direct is one of the leading providers in Business Services. It is based in Goleta, CA. To find more information about Avrick Direct, please visit www.avrick.com.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.avrick.com
  • 5951 Encina Rd Ste 104
    Goleta, CA USA 93117-6251
  • Phone: 805.963.8888

Executives

Name Title Contact Details

Similar Companies

Hospitality People the

Hospitality People the is a Independence, MO-based company in the Business Services sector.

Sifted

👋 Welcome to Sifted — the only read you need for staying up to speed on startup Europe. Looking for the next big thing in tech? Or maybe youve got your eye on a specific sector? Well save you hours of research with Sifted Pro, our premium subscription, where youll get access to: 🔎 100+ Briefings: packed with proprietary data on emerging sectors and geographic hotspots — keeping you ahead of the competition. 🗓️ Monthly events: Source new business opportunities with rising stars and leading industry players. ✍️ 120+ articles a month: Unlimited editorial access, helping your team track hot-topic trends, source scoops and debunk grapevine gossip. 🗞️ Weekly Pro newsletter: Stay on the cutting edge of European tech and ahead of market developments with exclusive subscriber-only insights. Subscribe to Sifted Pro at http://info.sifted.eu/subscribe-pro W: https://sifted.eu/ E: hello@sifted.eu

Imagine Print Group

Imagine Print Group is a Niles, IL-based company in the Business Services sector.

1k Studios

1k Studios is a Burbank, CA-based company in the Business Services sector.

DRI Healthcare

DRI Healthcare is a pioneer in global pharmaceutical royalty monetization. Over the course of three decades, we have been a trusted partner of royalty sellers and demonstrated strong execution, building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. That foundation sets us apart as we continue developing solutions for innovators while building and managing a risk-mitigated portfolio of therapeutic assets that generates attractive returns and growth potential for investors. We have deployed more than $2.5 billion, acquiring more than 70 royalties on 40-plus drugs.